AAAAAA
Results: 1-25/80
Authors:
TSAVARIS N
MYLONAKIS N
BACOYIANNIS C
KOSMAS C
KALERGIS G
IAKOVIDIS V
TZANINIS D
KOSMIDIS P
Citation: N. Tsavaris et al., FACTORS THAT INFLUENCE THE ANTIEMETIC ACTIVITY OF METOCLOPRAMIDE TO CISPLATIN-BASED CHEMOTHERAPY, Oncology Reports, 5(5), 1998, pp. 1147-1155
Authors:
FOUNTZILAS G
DIMOPOULOS AM
PAPADIMITRIOU C
KALOGERAFOUNTZILA A
ARAVANTINOS G
BAFALOAKOS D
ATHANASSIADES A
NICOLAIDES C
KERAMOPOULOS A
PAVLIDIS N
KOSMIDIS P
SKARLOS D
Citation: G. Fountzilas et al., FIRST-LINE CHEMOTHERAPY WITH PACLITAXEL BY 3-HOUR INFUSION AND CARBOPLATIN IN ADVANCED BREAST-CANCER (FINAL REPORT) - A PHASE-II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP, Annals of oncology, 9(9), 1998, pp. 1031-1034
Authors:
FOUNTZILAS G
BAFALOUKOS D
NIKOLAIDES C
ARAVANTINOS G
STATHOPOULOS G
APOSTOLIDOU K
KALOFONOS H
KOSMIDIS P
PAVLIDIS N
Citation: G. Fountzilas et al., DOCETAXEL (D) AND GEMCITABINE (G) IN ANTHRACYCLINE-RESISTANT ADVANCEDBREAST-CANCER (AR-ABC), Annals of oncology, 9, 1998, pp. 121-121
Authors:
KOSMIDIS P
SKARLOS D
KOUROUSSIS C
BOUKIS C
BIANCO AR
LELLI G
DELLACUNA GR
SCHULLER J
CALLAGHAN R
OULIDAISSA D
Citation: P. Kosmidis et al., BENEFIT OF GRANOCYTE(R) (LENOGRASTIM) IN PATIENTS TREATED WITH CAMPTO(R) (CPT-11) IN 1ST OR 2ND LINE METASTATIC COLORECTAL-CANCER (MCRC) - PRELIMINARY-RESULTS OF A PHASE-III MULTICENTER TRIAL, Annals of oncology, 9, 1998, pp. 162-162
Authors:
BAFALOUKOS D
SKARLOS D
FOUNTZILAS G
DIMOPOULOS AM
KOSMIDIS P
Citation: D. Bafaloukos et al., PACLITAXEL IN COMBINATION WITH DOXORUBICIN IN ADVANCED ADULT SOFT-TISSUE SARCOMA (ASTS) - A HELLENIC COOPERATIVE PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 575-575
Authors:
SCHRIJVERS D
JOHNSON J
JIMINEZ U
GORE M
KOSMIDIS P
SZPIRGLAS H
ROBBINS K
OLIVEIRA J
LEWENSOHN R
SCHULLER J
RIVIERE A
ARVAY C
LANGECKER P
JACOB H
CVITKOVIC E
VOKES E
Citation: D. Schrijvers et al., PHASE-III TRIAL OF MODULATION OF CISPLATIN FLUOROURACIL CHEMOTHERAPY BY INTERFERON-ALPHA-2B IN PATIENTS WITH RECURRENT OR METASTATIC HEAD AND NECK-CANCER/, Journal of clinical oncology, 16(3), 1998, pp. 1054-1059
Authors:
BRIASOULIS E
TSOKOS M
FOUNTZILAS G
BAFALOUKOS D
KOSMIDIS P
SAMANTAS E
SKARLOS D
NICOLAIDES C
PAVLIDIS N
Citation: E. Briasoulis et al., BCL2 AND P53 PROTEIN EXPRESSION IN METASTATIC CARCINOMA OF UNKNOWN PRIMARY ORIGIN - BIOLOGICAL AND CLINICAL IMPLICATIONS - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Anticancer research, 18(3B), 1998, pp. 1907-1914
Authors:
KALOGERAFOUNTZILA A
KOSMIDIS P
BACOYIANNIS C
NICOLAOU A
SAMANTAS E
BRIASSOULIS E
PAVLIDIS N
SKARLOS D
DANILIDIS J
FOUNTZILAS G
Citation: A. Kalogerafountzila et al., PROGNOSTIC FACTORS INFLUENCING COMPLETE RESPONSE TO TREATMENT AND SURVIVAL OF PATIENTS WITH NASOPHARYNGEAL CANCER, Anticancer research, 18(1B), 1998, pp. 587-593
Authors:
FOUNTZILAS GG
NICOLAIDES C
ARAVANTINOS G
SKARLOS D
KOSMIDIS P
PAPAKOSTAS P
STATHOPOULOS GP
KONTOSTOLIS E
BAFALOUKOS D
PAVLIDIS N
Citation: Gg. Fountzilas et al., DOSE-DENSE ADJUVANT CHEMOTHERAPY WITH EPIRUBICIN MONOTHERAPY IN PATIENTS WITH OPERABLE BREAST-CANCER AND GREATER-THAN-OR-EQUAL-TO-10 POSITIVE AXILLARY LYMPH-NODES - A FEASIBILITY STUDY, Oncology, 55(6), 1998, pp. 508-512
Authors:
TSAVARIS N
FOUNTZILAS G
MYLONAKIS N
ATHANASSIADIS A
KOSMAS C
KARAKOUSIS C
BACOYIANNIS C
KOSMIDIS P
Citation: N. Tsavaris et al., A RANDOMIZED COMPARATIVE-STUDY OF ANTIEMETIC PROPHYLAXIS WITH ONDANSENTRON IN A SINGLE 32-MG LOADING DOSE VERSUS 8 MG EVERY 6 H IN PATIENTSUNDERGOING CISPLATIN-BASED CHEMOTHERAPY, Oncology, 55(6), 1998, pp. 513-516
Authors:
NICOLAIDES C
FOUNTZILAS G
ZOUMBOS N
SKARLOS D
KOSMIDIS P
PECTASIDES D
KARABELIS A
GIANNAKAKIS T
SYMEONIDIS A
PAPADOPOULOS A
ANTONIOU F
PAVLIDIS N
Citation: C. Nicolaides et al., DIFFUSE LARGE-CELL LYMPHOMAS - IDENTIFICATION OF PROGNOSTIC FACTORS AND VALIDATION OF THE INTERNATIONAL NON-HODGKINS-LYMPHOMA PROGNOSTIC INDEX - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Oncology, 55(5), 1998, pp. 405-415
Authors:
BRIASOULIS E
TSAVARIS N
FOUNTZILAS G
ATHANASIADIS A
KOSMIDIS P
BAFALOUKOS D
SAMANTAS E
PAVLIDIS N
Citation: E. Briasoulis et al., COMBINATION REGIMEN WITH CARBOPLATIN, EPIRUBICIN AND ETOPOSIDE IN METASTATIC CARCINOMAS OF UNKNOWN PRIMARY SITE - A HELLENIC COOPERATIVE ONCOLOGY GROUP PHASE-II STUDY, Oncology, 55(5), 1998, pp. 426-430
Authors:
BAFALOUKOS D
FOUNTZILAS G
SKARLOS D
PAVLIDIS N
BAKOYIANNIS C
KARVOUNIS N
KOSMIDIS P
Citation: D. Bafaloukos et al., SUBCUTANEOUS LOW-DOSES OF INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA WITH CARBOPLATIN AND VINBLASTINE IN PATIENTS WITH ADVANCED MELANOMA, Oncology, 55(1), 1998, pp. 48-52
Authors:
BACOYIANNIS C
DIMOPOULOS MA
NICOLAIDES C
ARAVANTINOS G
XIROS N
SKARLOS D
PAVLIDIS N
KOSMIDIS P
Citation: C. Bacoyiannis et al., PHASE-II STUDY OF INTERFERON-GAMMA (RIFN-G) AND VINBLASTINE (VBL) IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA (RCC), European journal of cancer, 33, 1997, pp. 177-177
Authors:
KOSMIDIS P
BAFALOUKOS D
SKARLOS D
PAVLIDIS N
ARAVANTINOS G
ATHANASIADIS A
KARPATHIOS S
FOUNTZILAS G
Citation: P. Kosmidis et al., INTRAPERITONEAL (IP) INTERFERON A2B (INF) CONSOLIDATION IN CCR OVARIAN-CANCER (OC) PATIENTS FOLLOWING CARBOPLATIN CHEMOTHERAPY (CT), European journal of cancer, 33, 1997, pp. 385-385
Authors:
BAFALOUKOS D
ARAVANTINOS G
SKARLOS D
KATSIFIS G
BACOYIANNIS C
KOSMIDIS P
Citation: D. Bafaloukos et al., PHASE-II STUDY OF CARBOPLATIN BASED CHEMOTHERAPY IN COMBINATION WITH MEDROXYPROGESTERONE ACETATE (MPA) IN ADVANCED ENDOMETRIAL CANCER, European journal of cancer, 33, 1997, pp. 953-953
Authors:
BAFALOUKOS D
FOUNTZILAS G
SEMOGLOU C
VASILAKI V
KOSMIDIS P
Citation: D. Bafaloukos et al., PREDICTORS OF LONG-TERM SURVIVAL IN STAGE IV MALIGNANT-MELANOMA (MM) PATIENTS, European journal of cancer, 33, 1997, pp. 1166-1166
Authors:
TSAVARIS N
KOSMIDIS P
KOSMAS C
KATSIKAS M
BACOYIANNIS C
MYLONAKIS N
PAPALAMBROS E
KOUFOS C
BASTOUNIS E
SECHAS M
Citation: N. Tsavaris et al., CONTRIBUTION OF CHEMOTHERAPY (CMT) TO THE SURVIVAL(S) OF PATIENTS(P) WITH ADVANCED GASTRIC-CANCER (AGC) - A RETROSPECTIVE COMPARATIVE-STUDYOF PATIENTS WHO RECEIVED AND THOSE WHO REFUSED TREATMENT (TX), European journal of cancer, 33, 1997, pp. 1276-1276
Authors:
FOUNTZILAS G
ATHANASSIADIS A
KALOGERAFOUNTZILA A
ARAVANTINOS G
BAFALOUKOS D
BRIASOULIS E
DOMBROS N
IOANNIDIS I
PAVLIDIS N
KOSMIDIS P
SKARLOS D
Citation: G. Fountzilas et al., PACLITAXEL BY 3-H INFUSION AND CARBOPLATIN IN ANTHRACYCLINE-RESISTANTADVANCED BREAST-CANCER - A PHASE-II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP, European journal of cancer, 33(11), 1997, pp. 1893-1895
Authors:
ARAVANTINOS G
SKARLOS DV
KOSMIDIS P
ATHANASSIADES A
BAFALOUKOS D
GIANNAKAKIS T
KARPATHIOS S
FOUNTZILAS G
Citation: G. Aravantinos et al., A PHASE-II STUDY OF PACLITAXEL IN PLATINUM PRETREATED OVARIAN-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, European journal of cancer, 33(1), 1997, pp. 160-163
Authors:
FOUNTZILAS G
SKARLOS D
ATHANASSIADES A
KALOGERAFOUNTZILA A
SAMANTAS E
BACOYIANNIS C
NICOLAOU A
DOMBROS N
BRIASOULIS E
DINOPOULOU M
STATHOPOULOS G
PAVLIDIS N
KOSMIDIS P
DANIILIDIS J
Citation: G. Fountzilas et al., PACLITAXEL BY 3-HOUR INFUSION AND CARBOPLATIN IN ADVANCED-CARCINOMA OF NASOPHARYNX AND OTHER SITES OF THE HEAD AND NECK - A PHASE-II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP, Annals of oncology, 8(5), 1997, pp. 451-455
Authors:
FOUNTZILAS G
ATHANASSIADES A
GIANNAKAKIS T
BRIASOULIS E
BAFALOUKOS D
KALOGERAFOUNTZILA A
ONIENAOUM A
KALOFONOS H
PECTASIDES D
ANDREOPOULOU E
BAMIA C
KOSMIDIS P
PAVLIDIS N
SKARLOS D
Citation: G. Fountzilas et al., A RANDOMIZED STUDY OF EPIRUBICIN MONOTHERAPY EVERY 4 OR EVERY 2 WEEKSIN ADVANCED BREAST-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Annals of oncology, 8(12), 1997, pp. 1213-1220
Authors:
NICOLAIDES C
KLOUVAS G
FOUNTZILAS G
ATHANASSIADIS A
SKARLOS D
SAMANTAS E
KOSMIDIS P
MYLONAKIS N
PAVLIDIS N
Citation: C. Nicolaides et al., INTENSIFIED CARBOPLATIN REGIMEN WITH GM-CSF SUPPORT IN NONSMALL CELL LUNG-CANCER (NSCLC) - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY (HECOG), Journal of experimental & clinical cancer research, 16(1), 1997, pp. 91-94
Authors:
FOUNTZILAS G
VASILAROS S
KOUKOURAS D
MALAMOS N
PECTASIDES D
ADAMOU A
NENOPOULOU E
KIRIAKOU K
ZOUVANI I
KATSOHIS K
KAPPAS A
SKOPA C
SEMOGLOU C
FAHANTIDIS E
KONSTANTARAS C
VASILAKI E
ECONOMOPOULOS T
BACOYIANNIS H
BAFALOUKOS D
RAZI E
POLICHRONIS A
ANDROULAKIS G
PAPAIOANNOU T
PAVLIDIS N
SKARLOS D
KOSMIDIS P
Citation: G. Fountzilas et al., PROGNOSTIC VARIABLES IN CREEK PATIENTS WITH STAGE-II BREAST-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Anticancer research, 17(6D), 1997, pp. 4681-4689
Authors:
TSAVARIS N
PRIMIKIRIOS N
MYLONAKIS N
VAROUCHAKIS G
DOSIOS T
PAVLIDIS N
SKARLOS D
TASOPOULOS T
DRITSAS J
KOSMIDIS P
Citation: N. Tsavaris et al., COMBINATION CHEMOTHERAPY WITH CISPLATIN AND OR DOXORUBICIN IN MALIGNANT MESOTHELIOMA - A PROSPECTIVE-STUDY/, Anticancer research, 17(5B), 1997, pp. 3799-3802